MAT1A variants modulate the effect of dietary fatty acids on plasma homocysteine concentrations

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 22, Issue 4, 2012, Pages 362-368

  Huang, T ^a,b,d   Tucker, K ^c   Lee, Y ^b   Crott, J ^b   Parnell, L ^b   Shen, J ^b   Smith, C ^b   Ordovas, J ^b   Li, D ^a,d   Lai, C ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b TUFTS UNIVERSITY   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d APCNS Centre of Nutrition and Food Safety   (China)

Author keywords

Dietary fatty acids; Methionine adenosyltransferase; Plasma homocysteine

Indexed keywords

HOMOCYSTEINE; MAT1A PROTEIN, HUMAN; METHIONINE ADENOSYLTRANSFERASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

AGED; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CROSS-SECTIONAL STUDIES; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HOMOCYSTEINE; HUMANS; MALE; METHIONINE ADENOSYLTRANSFERASE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84858450322     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.07.015     Document Type: Article

References (27)

1. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969, 56:111-128.
2. Refsum H., Ueland P.M., Nygard O., Vollset S.E. Homocysteine and cardiovascular disease. Annu Rev Med 1998, 49:31-62.
3. Huang T., Yuan G., Zhang Z., Zou Z., Li D. Cardiovascular pathogenesis in hyperhomocysteinemia. Asia Pac J Clin Nutr 2008, 17:8-16.
4. Blom H.J. Determinants of plasma homocysteine. Am J Clin Nutr 1998, 67:188-189.
5. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
6. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998, 64:169-172.
7. Wilson A., Platt R., Wu Q., Leclerc D., Christensen B., Yang H., et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999, 67:317-323.
8. Leclerc D., Campeau E., Goyette P., Adjalla C.E., Christensen B., Ross M., et al. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet 1996, 5:1867-1874.
9. Selhub J., Jacques P.F., Rosenberg I.H., Rogers G., Bowman B.A., Gunter E.W., et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999, 131:331-339.
10. Schneede J., Refsum H., Ueland P.M. Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000, 26:263-279.
11. Erkkila A.T., Lichtenstein A.H., Mozaffarian D., Herrington D.M. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 2004, 80:626-632.
12. Li D., Mann N.J., Sinclair A.J. A significant inverse relationship between concentrations of plasma homocysteine and phospholipid docosahexaenoic acid in healthy male subjects. Lipids 2006, 41:85-89.
13. Li D., Yu X.M., Xie H.B., Zhang Y.H., Wang Q., Zhou X.Q., et al. Platelet phospholipid n-3 PUFA negatively associated with plasma homocysteine in middle-aged and geriatric hyperlipaemia patients. Prostaglandins Leukot Essent Fatty Acids 2007, 76:293-297.
14. Grundt H., Nilsen D.W., Mansoor M.A., Hetland O., Nordoy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 2003, 33:88-95.
15. Piolot A., Blache D., Boulet L., Fortin L.J., Dubreuil D., Marcoux C., et al. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health. J Lab Clin Med 2003, 141:41-49.
16. Lai C.Q., Parnell L.D., Troen A.M., Shen J., Caouette H., Warodomwichit D., et al. MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. Am J Clin Nutr 2010, 91:1377-1386.
17. Tucker K.L., Mattei J., Noel S.E., Collado B.M., Mendez J., Nelson J., et al. The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public Health 2010, 10:107.
18. Tucker K.L., Bianchi L.A., Maras J., Bermudez O.I. Adaptation of a food frequency questionnaire to assess diets of Puerto Rican and non-Hispanic adults. Am J Epidemiol 1998, 148:507-518.
19. Lee I.M., Paffenbarger R.S. Physical activity and stroke incidence: the Harvard Alumni health study. Stroke 1998, 29:2049-2054.
20. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005, 37:1217-1223.
21. Araki A., Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987, 422:43-52.
22. Camp V.M., Chipponi J., Faraj B.A. Radioenzymatic assay for direct measurement of plasma pyridoxal 5'- phosphate. Clin Chem 1983, 29:642-644.
23. Soldin S.J., Wan B.S., Cherian A.G. The measurement of creatinine: a comparison between the Beckman creatinine Analyzer II and the Selective Analyzer GSA IID. Clin Biochem 1981, 14:165-168.
24. Zeman M., Zak A., Vecka M., Tvrzicka E., Pisarikova A., Stankova B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J Nutr Biochem 2006, 17:379-384.
25. Pooya S., Jalali M.D., Jazayery A.D., Saedisomeolia A., Eshraghian M.R., Toorang F. The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2009.
26. Ubagai T., Lei K.J., Huang S., Mudd S.H., Levy H.L., Chou J.Y. Molecular mechanisms of an inborn error of methionine pathway. Methionine adenosyltransferase deficiency. J Clin Invest 1995, 96:1943-1947.
27. Huang T., Wahlqvist M.L., Li D. Docosahexaenoic acid decreases plasma homocysteine via regulating enzyme activity and mRNA expression involved in methionine metabolism. Nutrition 2008, 26:112-119.